{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:01:05Z","timestamp":1788174065343,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T00:00:00Z","timestamp":1416528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s12026-014-8596-y","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T15:26:54Z","timestamp":1416583614000},"page":"160-163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Lupus and leprosy: beyond the coincidence"],"prefix":"10.1007","volume":"61","author":[{"given":"F. M.","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. E.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. M. N.","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. M.","family":"Klumb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,21]]},"reference":[{"key":"8596_CR1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/rheumatology\/40.2.152","volume":"40","author":"TC Hsu","year":"2001","unstructured":"Hsu TC, Tsay GJ. Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2001;40:152\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"8596_CR2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1386-6532(99)00038-4","volume":"14","author":"A Hemauer","year":"1999","unstructured":"Hemauer A, Beckenlehner K, Wolf H, Lang B, Modrow S. Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient. J Clin Virol. 1999;14:73\u20137.","journal-title":"J Clin Virol"},{"key":"8596_CR3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/08916930500285352","volume":"38","author":"GZ Goddard","year":"2005","unstructured":"Goddard GZ, Shoenfeld Y. Infections and SLE. Autoimmunity. 2005;38:473\u201385.","journal-title":"Autoimmunity"},{"key":"8596_CR4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1191\/096120398678920596","volume":"7","author":"T Hayashi","year":"1998","unstructured":"Hayashi T, Lee S, Ogasawara H, Sekigawa I. Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection. Lupus. 1998;7:561\u20134.","journal-title":"Lupus"},{"key":"8596_CR5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/ijr.09.72","volume":"5","author":"L Francis","year":"2010","unstructured":"Francis L, Perl A. Infection in systemic lupus erythematosus: friend or foe? Int J Clin Rheumtol. 2010;5:59\u201374.","journal-title":"Int J Clin Rheumtol"},{"key":"8596_CR6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12016-009-8149-7","volume":"38","author":"FM Ribeiro","year":"2010","unstructured":"Ribeiro FM, Szyper-Kravitz M, Klumb EM, et al. Can lupus flares be associated with tuberculosis infection? Clin Rev Allergy Immunol. 2010;38:163\u20138.","journal-title":"Clin Rev Allergy Immunol"},{"key":"8596_CR7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0167-5699(88)91294-7","volume":"9","author":"Y Shoenfeld","year":"1988","unstructured":"Shoenfeld Y, Isenberg DA. Mycobacteria and autoimmunity. Immunol Today. 1988;9:178\u201381.","journal-title":"Immunol Today"},{"key":"8596_CR8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/art.1780300107","volume":"30","author":"O Sela","year":"1987","unstructured":"Sela O, El-Roeiy A, DA Isenberg J, et al. A common anti-DNA antibody idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum. 1987;30:50\u20135.","journal-title":"Arthritis Rheum"},{"key":"8596_CR9","first-page":"171","volume":"58","author":"R Carducci","year":"1978","unstructured":"Carducci R, Teralbini CGL, Tak CG. Autoantibodies in leprosy. Int J Lepr. 1978;58:171\u20135.","journal-title":"Int J Lepr"},{"key":"8596_CR10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF02231680","volume":"15","author":"LS Guedes Barbosa","year":"1996","unstructured":"Guedes Barbosa LS, Gilbrut B, Shoenfeld Y, Sheinberg MA. Autoantibodies in leprosy sera. Clin Rheumatol. 1996;15:26\u20138.","journal-title":"Clin Rheumatol"},{"key":"8596_CR11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ad.2012.03.003","volume":"104","author":"K Eichelmann","year":"2013","unstructured":"Eichelmann K, Gonz\u00e1lez Gonz\u00e1lez SE, Salas-Alanis JC, Ocampo-Candiani J. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment. Actas Dermosifiliogr. 2013;104:554\u201363.","journal-title":"Actas Dermosifiliogr"},{"key":"8596_CR12","first-page":"337","volume":"85","author":"Global leprosy situation","year":"2010","unstructured":"Global leprosy situation. Wkly Epidemiol Rec. 2010;85:337\u201348.","journal-title":"Wkly Epidemiol Rec"},{"key":"8596_CR13","first-page":"2","volume":"27","author":"A Gulia","year":"2010","unstructured":"Gulia A, Fried I, Massone C. New insights in the pathogenesis and genetics of leprosy. F1000 Medicine Reports. 2010;27:2.","journal-title":"F1000 Medicine Reports"},{"key":"8596_CR14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","volume":"19","author":"DM Scollard","year":"2006","unstructured":"Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev. 2006;19:338\u201381.","journal-title":"Clin Microbiol Rev"},{"key":"8596_CR15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1440-1711.2000.00935.x","volume":"78","author":"C Demangel","year":"2000","unstructured":"Demangel C, Britton WJ. Interaction of dendritic cells with mycobacteria: where the action starts. Immunol Cell Biol. 2000;78:318\u201324.","journal-title":"Immunol Cell Biol"},{"key":"8596_CR16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1462-5822.2009.01377.x","volume":"12","author":"LS Rodrigues","year":"2010","unstructured":"Rodrigues LS, da Silva Maeda E, et al. Mycobacterium leprae induces insulin-like growth factor and promotes survival of Schwann cells upon serum withdrawal. Cell Microbiol. 2010;12:42\u201354.","journal-title":"Cell Microbiol"},{"issue":"62","key":"8596_CR17","first-page":"559","volume":"1994","author":"DM Scollard","year":"1994","unstructured":"Scollard DM, Smith T, Bhoopat L, Theetranont C, Rangdaeng S, Morens DM. Epidemiologic characteristics of leprosy reactions. Int J Lepr Other Mycobact Dis. 1994;1994(62):559\u201367.","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"8596_CR18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1489\/1544-581X(2004)072<0125:ECOLRY>2.0.CO;2","volume":"72","author":"B Kumar","year":"2004","unstructured":"Kumar B, Dogra S, Kaur I. Epidemiological characteristics of leprosy reactions: 15\u00a0years experience from North India. Int J Lepr Other Mycobact Dis. 2004;72:125\u201333.","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"8596_CR19","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s10067-013-2276-5","volume":"32","author":"S Salvi","year":"2013","unstructured":"Salvi S, Chopra A. Leprosy in a rheumatology setting: a challenging mimic to expose. Clin Rheumatol. 2013;32:1557\u201363.","journal-title":"Clin Rheumatol"},{"key":"8596_CR20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1590\/S0037-86822011000100019","volume":"44","author":"GJ Teixeira J\u00fanior","year":"2011","unstructured":"Teixeira J\u00fanior GJ, Silva CEF, Magalh\u00e3es V. Application of the diagnostic criteria for systemic lupus erythematosus to patients with multibacillary leprosy. Rev Soc Bras Med Trop. 2011;44:85\u201390.","journal-title":"Rev Soc Bras Med Trop"},{"key":"8596_CR21","first-page":"900","volume":"20","author":"Garcia-de Torre la","year":"1993","unstructured":"la Torre Garcia-de. I. Autoimmune phenomena in leprosy, particularly antinuclear antibodies and rheumatoid factor. J Rheumatol. 1993;20:900\u20133.","journal-title":"J Rheumatol"},{"key":"8596_CR22","first-page":"199","volume":"64","author":"G Kroumpouzos","year":"1993","unstructured":"Kroumpouzos G, Vareltzidis A, Konstadoulakis MM, et al. Evaluation of the autoimmune response in leprosy. Lepr Rev. 1993;64:199\u2013207.","journal-title":"Lepr Rev"},{"key":"8596_CR23","first-page":"108","volume":"14","author":"RA Miller","year":"1987","unstructured":"Miller RA, Wener MH, Harnisch JP, Gilliland BC. The limited spectrum of antinuclear antibodies in leprosy. J Rheumatol. 1987;14:108\u201310.","journal-title":"J Rheumatol"},{"key":"8596_CR24","first-page":"159","volume":"50","author":"VK Sharma","year":"1982","unstructured":"Sharma VK, Saha K, Sehgal VN. Serum immunoglobulins and autoantibodies during and after erythema nodosum leprosum (ENL). Int J Lepr Other Mycobact Dis. 1982;50:159\u201363.","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"8596_CR25","first-page":"171","volume":"47","author":"C Masala","year":"1979","unstructured":"Masala C, Amendolea MA, Nuti M, Riccarducci R, Tarabini CG, Tarabini CG. Autoanibodies in leprosy. Int J Lepr Other Mycobac Dis. 1979;47:171\u20135.","journal-title":"Int J Lepr Other Mycobac Dis"},{"key":"8596_CR26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF02231680","volume":"15","author":"LS Guedes-Barbosa","year":"1996","unstructured":"Guedes-Barbosa LS, Gilbrut B, Shoenfeld Y, Scheinberg MA. Autoantibodies in leprosy sera. Clin Rheumatol. 1996;15:26\u20138.","journal-title":"Clin Rheumatol"},{"key":"8596_CR27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/B978-044450987-1\/50033-4","volume-title":"The antiphospholipid syndrome II","author":"G Zandman-Goddard","year":"2002","unstructured":"Zandman-Goddard G, Blank M, Shoenfeld Y. Antiphospholipid antibodies and infections-drugs. In: Asherson RA, Cervera R, Piette JC, Shoenfeld Y, editors. The antiphospholipid syndrome II. Amsterdan: Elsevier Science; 2002. p. 343\u201360."},{"key":"8596_CR28","first-page":"492","volume":"18","author":"A Elbeialy","year":"2000","unstructured":"Elbeialy A, Strassburger-Lorna K, Altsumi T, et al. Antiphospholipid antibodies in leprotic patients: a correlation with disease manifestation. Clin Exp Rheumatol. 2000;18:492\u20134.","journal-title":"Clin Exp Rheumatol"},{"key":"8596_CR29","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/ard.62.11.1106","volume":"62","author":"S Loizou","year":"2003","unstructured":"Loizou S, Singh S, Wypkema E, Asherson RA. Anticardiolipin anti- beta2-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann Rheum Dis. 2003;62:1106\u201311.","journal-title":"Ann Rheum Dis"},{"key":"8596_CR30","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1191\/096120300678828712","volume":"9","author":"GF Laranaga de","year":"2000","unstructured":"de Laranaga GF, Forastiero RR, Martinuzzo ME, et al. High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity. Lupus. 2000;9:594\u2013600.","journal-title":"Lupus"},{"key":"8596_CR31","first-page":"529","volume":"70","author":"E Bonfa","year":"1987","unstructured":"Bonfa E, Llovet R, Scheinberg M, de Souza JM, Elkon KB. Comparison between autoantibodies in malaria and leprosy with lupus. Clin Exp Immunol. 1987;70:529\u201337.","journal-title":"Clin Exp Immunol"},{"key":"8596_CR32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/096120339400300615","volume":"3","author":"M Hojnik","year":"1994","unstructured":"Hojnik M, Gilburd B, Ziporen L, et al. Anticardiolipin antibodies in infections are heterogeneous in their dependency on \u00df2-GPI: analysis of anticardiolipina antibodies in leprosy. Lupus. 1994;3:515\u201321.","journal-title":"Lupus"},{"issue":"suppl","key":"8596_CR33","first-page":"I476","volume":"43","author":"RA Levy","year":"2000","unstructured":"Levy RA, Pierangeli SA, Espinola RG. Antiphospholipid beta-2 glycoprotein I dependency assay to determine antibody pathogenicity. Arthritis Rheuma. 2000;43(suppl):I476.","journal-title":"Arthritis Rheuma"},{"key":"8596_CR34","first-page":"30","volume":"36","author":"SLE Ribeiro","year":"2011","unstructured":"Ribeiro SLE, Pereira HLA, Silva NP, Souza AWS, Sato EI. Anti- \u00df2 glycoprotein I antibodies are highly prevalent in a large number of Brazilian leprosy patients. Acta Reumatol Port. 2011;36:30\u20137.","journal-title":"Acta Reumatol Port"},{"key":"8596_CR35","first-page":"12","volume":"27","author":"RA Asherson","year":"2000","unstructured":"Asherson RA, Shoenfeld Y. The role of infections in the pathogenesis of catasthrophic antiphospholipid syndrome\u2014molecular mimicry? J Rheumatol. 2000;27:12\u20134.","journal-title":"J Rheumatol"},{"key":"8596_CR36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0167-5699(88)91294-7","volume":"9","author":"Y Shoenfeld","year":"1988","unstructured":"Shoenfeld Y, Isenberg DA. Mycobacteria and autoimmunity. Immunol Today. 1988;9:178\u201381.","journal-title":"Immunol Today"},{"key":"8596_CR37","first-page":"255","volume":"66","author":"Y Shoenfeld","year":"1986","unstructured":"Shoenfeld Y, Vilner Y, Coates AR, et al. Monoclonal anti- tuberculosis antibodies react with DNA and monoclonal anti- DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol. 1986;66:255\u201361.","journal-title":"Clin Exp Immunol"},{"key":"8596_CR38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/08916938909014704","volume":"4","author":"H Amital-Teplizic","year":"1989","unstructured":"Amital-Teplizic H, Avinoach I, Coates AR, Kooperman O, Blank M, Shoenfeld Y. Binding of monoclonal anti-DNA and anti-TB glycolipids to brain tissue. Autoimmunity. 1989;4:277\u201387.","journal-title":"Autoimmunity"},{"key":"8596_CR39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/art.1780300107","volume":"30","author":"O Sela","year":"1987","unstructured":"Sela O, El-Roeiy A, Isenberg DA, et al. A common anti-DNA antibody idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum. 1987;30:50\u20135.","journal-title":"Arthritis Rheum"},{"key":"8596_CR40","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1172\/JCI112849","volume":"79","author":"CG Mackworth-Young","year":"1987","unstructured":"Mackworth-Young CG, Sabbaga J, Schwartz RS. Idiotypic markers of polyclonal B cell activation. Public idiotypes shared by monoclonal antibodies derived from patients with systemic lupus erythematosus or leprosy. J Clin Invest. 1987;79:572\u201381.","journal-title":"J Clin Invest"},{"key":"8596_CR41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2249.1990.tb05130.x","volume":"79","author":"CG Mackworth-Young","year":"1990","unstructured":"Mackworth-Young CG. Cross-reactive idiotypes in sera from patients with leprosy, lupus and Lyme disease and from healthy individuals. Clin Exp Immunol. 1990;79:78\u201382.","journal-title":"Clin Exp Immunol"},{"key":"8596_CR42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0896-8411(05)80009-5","volume":"3","author":"CG Mackworth-Young","year":"1990","unstructured":"Mackworth-Young CG, Cairns E, Sabbaga J, et al. Comparative study of idiotypes on monoclonal antibodies derived from patients with lupus and leprosy and from normal individuals. J Autoimmunity. 1990;3:415\u20139.","journal-title":"J Autoimmunity"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-014-8596-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-014-8596-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-014-8596-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T17:54:51Z","timestamp":1566064491000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-014-8596-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,21]]},"references-count":42,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["8596"],"URL":"https:\/\/doi.org\/10.1007\/s12026-014-8596-y","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,21]]}}}